Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

Antonella Converso(United States Military Academy), George D. Hartman(United States Military Academy), Mark E. Fraley(United States Military Academy), Edward S. Tasber(United States Military Academy), Xianzhi Mao(United States Military Academy), Steve Stirdivant(United States Military Academy), Sylvie Marie Jezequel-Sur(United States Military Academy), Rob Lobell(United States Military Academy), Joan Zugay-Murphy(United States Military Academy), Marc Abrams(Thomas Jefferson University), Keith Rickert(United States Military Academy), Laura Sepp‐Lorenzino(United States Military Academy), Bob Drakas(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carolyn A. Buser(United States Military Academy), Paul Zuck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Constantine Kreatsoulas(United States Military Academy), Sanjeev Munshi(United States Military Academy), Youwei Yan(United States Military Academy), Stephen C. Beck(United States Military Academy), Timothy J. Hartingh(United States Military Academy), Weikang Tao(Jiangsu Hengrui Medicine (China)), Vinod Sardana(United States Military Academy)
Bioorganic & Medicinal Chemistry Letters
December 26, 2008
Cited by 74


Related Papers